• SENSEX 73,694.89
    448.86 (+0.61%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,380.50 1,356.40(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • PTC Industries
    24,750.00 26,049.95(%)
  • NSE
    1,795.00 1,878.00(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Aeroflex
    579.00 613.50(%)
  • Pidilite Inds.
    1,429.05 1,707.95(%)
  • The Bombay Burmah
    1,176.50 1,108.20(%)
  • Billionbrains
    189.10 112.02(%)
  • Cholaman.Inv.&Fn
    1,589.95 1,952.00(%)
  • Bajaj Finance
    932.45 1,177.60(%)
  • Birlasoft Ltd
    351.80 473.75(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • M & M Fin. Serv.
    256.60 253.30(%)
  • Adani Ports
    1,857.35 1,891.80(%)
  • Coromandel Inter
    1,734.65 2,496.10(%)
  • Tube Investments
    2,098.60 2,006.00(%)
  • JSW Dulux
    286.50 374.67(%)
  • Acutaas Chemical
    4,000.00 3,977.00(%)
  • Moneyview
    52.44 65.43(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Tatva Chintan Pharma Chem Ltd Chemicals

  • Indian Private
  • BSE Code : 75545.0
  • ISIN : INE0GK401011
1,627.80 22 (1.40%)
  • As on 29 Oct 2026 (EOD)
  • Today’s Low

    1,591.00
  • Today’s High

    1,660.00
  • Open

    1,614.00
  • Perv Close

    1,605.40
  • 52W Low

    1,044.10
  • 52W High

    2,113.60

Key Indicators

  • P/E(TTM)

    73.18

  • Mar.Cap (₹Cr.)

    3,807.76

  • Div & Yield %

    0.12

  • Book Value(₹)

    333.22

  • Debt-Equity Ratio

    1.40

  • AGM Date

    28-Oct-2026

  • EPS

    22.15

  • P/E Ratio

    73.18

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    3,807.76

  • RONW (%)

    4.85

  • ROCE (%)

    6.99

Score Board

  • Equity (₹ in Cr.)

    23.39

  • BV (₹)

    333.20

  • Sales( ₹ in Cr.)

    496.30

  • NP (in Cr.)

    39.12

  • NP Var(%)

    10842.0

  • Div%

    20.0

  • CPS (₹)

    32.50

  • EPS (₹)

    16.70

  • Traded Value (₹ in Lakhs)

    3,791.85

  • 52 Week High

    2,113.60

  • 52 Week Low

    1,044.10

  • Price BSE

    1621.0

  • Price NSE

    1,628.00

  • Market Capital( in Cr.)

    3,791.85

  • P/C Ratio

    49.90

  • P/E Ratio

    96.90

  • Price Vs.BV

    16.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 496.30 366.42 378.68 403.04 427.81 291.19
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 496.30 366.42 378.68 403.04 427.81 291.19
Other Income 3.53 3.56 7.51 5.68 10.63 5.10
Stock Adjustments 31.79 -23.90 10.72 -6.51 58.04 5.20
Total Income 531.62 346.08 396.91 402.21 496.48 301.49
EXPENDITURE :            
Raw Materials 262.75 173.76 178.76 215.82 254.49 153.53
Power and Fuel Cost 44.84 34.44 34.78 23.61 22.62 9.92
Employee Cost 62.93 52.92 54.76 41.21 30.82 23.80
Other Manufacturing Expenses 24.95 17.57 19.59 18.03 23.95 16.45
Selling and Administration Expenses 42.50 36.43 32.62 38.63 46.95 26.53
Miscellaneous Expenses 0.64 1.39 1.88 8.01 1.01 0.76
Employee Benefit Expenses 62.93 52.92 54.76 41.21 30.82 23.80
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 438.60 316.51 322.38 345.31 379.85 231.00
Operating Profit 93.02 29.57 74.53 56.91 116.64 70.49
Interest 3.01 1.45 6.66 8.52 5.19 4.41
Gross Profit 90.01 28.12 67.87 48.39 111.45 66.08
Depreciation 36.84 27.65 25.60 9.55 8.18 6.73
Profit Before Tax 53.17 0.47 42.27 38.84 103.27 59.35
Current Tax 10.07 0.00 7.34 -2.80 18.01 10.43
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.02 0.13 5.57 1.17 -10.73 -2.44
Reported Net Profit 39.08 0.33 29.35 40.47 95.99 51.36
Extraordinary Items -0.04 -0.03 -0.08 -3.31 -0.04 -0.03
Adjusted Net Profit 39.12 0.36 29.43 43.78 96.03 51.39
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -12.05
P & L Balance brought forward 294.23 298.58 273.91 237.88 141.89 106.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.34 4.68 4.68 4.43 0.00 4.02
P & L Balance carried down 330.97 294.23 298.58 273.91 237.88 141.89
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 10.00 20.00 20.00 20.00 50.00
Dividend Per Share(Rs) 2.00 1.00 2.00 2.00 2.00 5.00
Earnings Per Share-Unit Curr 16.71 0.14 12.55 18.26 43.31 25.57
Earnings Per Share(Adj)-Unit Curr 16.71 0.14 12.55 18.26 43.31 -
Book Value 324.14 308.36 310.31 227.74 211.54 80.61
Book Value(Adj)-Unit Curr 324.14 308.36 310.31 227.74 211.54 -

Shareholding Pattern

  • Promoter Group

    72.02%

  • Public Share Holding

    27.98%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,846,963 72.02 16,846,963 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,846,963 72.02 16,846,963 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 7 0.00 7 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,024,137 4.38 1,024,137 33
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 670,814 2.87 670,814 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 80,615 0.34 80,615 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,775,573 7.59 1,775,573 44
2] Non Institution
Bodies Corporate 363,999 1.56 363,999 246
Clearing Members 9,668 0.04 9,668 15
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 218,689 0.93 218,689 1,031
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 147,812 0.63 147,812 1,402
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 706,185 3.02 706,185 5
Individuals holding nominal share capital up to Rs. 1 lakh 3,290,312 14.07 3,290,312 60,113
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,769,519 20.39 4,769,519 62,833
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,392,055 100.00 23,392,055 62,888

Company Background

Tatva Chintan Pharma Chem LtdChemicals

  • Tatva Chintan Pharma Chem Ltd
  • BSE Code : 75545.0
  • ISIN : INE0GK401011
  • Incorporation Year

    1996

  • Registered Office

    No 502/17 GIDC Estate
    Ankleshwar, Bharuch,
    Gujarat-393002

  • Telephone

    +91-75730-46951/46952

  • FAX

  • Chairman

    Chintan Nitinkumar Shah

  • Managing Director

    Chintan Nitinkumar Shah

  • Company Secretary

    Ishwar Nayi

  • Auditor

    NDJ & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Tatva Chintan Pharma Chem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Tatva Chintan 1,621.00 499.82 496.30 74.60 6.84
Atul 5,219.05 5,762.48 5,563.57 23.02 13.08
BASF India 3,108.55 15,055.73 14,985.40 21.30 14.31
Deepak Nitrite 1,487.70 2,760.32 2,639.46 90.88 7.08
Deepak Fertilis. 1,161.80 2,148.20 1,963.67 58.50 8.30
Advance Petroch. 869.65 47.45 47.36 38.06 7.35
Oriental Aromat. 627.00 1,034.96 1,025.57 76.18 6.21
DIC India 525.55 897.86 891.79 16.67 5.83
Sudarshan Colorants 439.40 807.47 780.63 21.22 10.32
DMCC Speciality 297.15 582.54 581.50 18.54 14.64
Citurgia Biochem 102.45 0.00 0.00 -1,707.50 0.00